
Neurotechnology accelerator links commercialization gaps to concrete deliverables
Most early-stage neurotechnology teams selected for the NIH Blueprint MedTech Seedling Program advanced to an internal review of potential Optimizer Award funding after completing six months of structured work, according to a descriptive


